The CAMbridge pulmonary hypertension outcome review (CAMPHOR): development and validation

N. Doughty, S. P. McKenna, D. Meads, J. Pepke Zaba (Cambridge, Manchester, United Kingdom)

Source: Annual Congress 2004 - Pulmonary hypertension
Session: Pulmonary hypertension
Session type: Thematic Poster Session
Number: 777

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Doughty, S. P. McKenna, D. Meads, J. Pepke Zaba (Cambridge, Manchester, United Kingdom). The CAMbridge pulmonary hypertension outcome review (CAMPHOR): development and validation. Eur Respir J 2004; 24: Suppl. 48, 777

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cambridge pulmonary hypertension outcomes review (CAMPHOR) utility assessment in pulmonary hypertension (PH) patients
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007


Responsiveness of cambridge pulmonary hypertension outcome review (CAMPHOR) scores and utility in pulmonary hypertension (PH) patients
Source: Eur Respir J 2007; 30: Suppl. 51, 343s
Year: 2007

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
Source: Eur Respir J, 50 (2) 1700889; 10.1183/13993003.00889-2017
Year: 2017



EmPHasis-10 is associated with clinical outcome measures in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013


CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 56 (4) 1902096; 10.1183/13993003.02096-2019
Year: 2020



Outcomes measures used in studies of exercise rehabilitation in pulmonary hypertension: a systematic review
Source: Virtual Congress 2020 – Novel insights into exercise training
Year: 2020


Pulmonary rehabilitation in patients with group 3 pulmonary hypertension: evaluation of clinical outcomes, adherence and safety.
Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today
Year: 2019


Psychometric validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012

Treatment of pulmonary hypertension associated with COPD: a systematic review
Source: ERJ Open Res, 8 (1) 00348-2021; 10.1183/23120541.00348-2021
Year: 2022



The clinical efficacy of pulmonary hypertension-specific agents in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019

Outcomes and measures of pulmonary rehabilitation in patients with COPD: a systematic review
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021


External validation of the REVEAL risk score calculator for PAH survival: A French pulmonary hypertension network analysis
Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries
Year: 2012


Pulmonary hypertension in COPD patients: a systematic review and meta-analysis
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019


Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Source: Eur Respir J, 53 (1) 1801913; 10.1183/13993003.01913-2018
Year: 2019



Validation of the COPD severity score for use in primary care: the NEREA study
Source: Eur Respir J 2009; 33: 519-527
Year: 2009



An international survey of current pulmonary arterial hypertension (PAH) management
Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments
Year: 2012


Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry
Source: Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019
Year: 2020



PROs: which instruments are available in pulmonary hypertension?
Source: Virtual Congress 2020 – Pulmonary vascular diseases
Year: 2020


Pulmonary hypertension and lung diseases: a suggestion for revision of the clinical classification
Source: Eur Respir J 2010; 35: 700-701
Year: 2010


Portuguese validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) questionnaire
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014